FDA approves Amgen colon cancer drug Vectibix
(Reuters
Reuters - The U.S. Food and Drug
Administration said on Wednesday it had approved Amgen Inc.'s
drug Vectibix for use in colon cancer patients whose tumors
have spread despite chemotherapy treatment.
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace